Risk factors for atherosclerosis in patients with chronic kidney disease: Recognition and management

Current Opinion in Pharmacology

Volumn 13, Issue 2, 2013, Pages 192-199

  Balla, Sudarshan ^a   Nusair, Maen B ^a   Alpert, Martin A ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA TOCOPHEROL; ANGIOTENSIN RECEPTOR ANTAGONIST; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ACETATE; CALCIUM CARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CYANOCOBALAMIN; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EZETIMIBE PLUS SIMVASTATIN; FOLIC ACID; GLIPIZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOOP DIURETIC AGENT; METFORMIN; PLACEBO; PYRIDOXINE; ROSUVASTATIN; SEVELAMER; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

ADRENERGIC SYSTEM; AGING; ANEMIA; ATHEROSCLEROSIS; BLOOD VESSEL CALCIFICATION; CALCIFICATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CORONARY ARTERY CALCIFICATION; DIABETES MELLITUS; DRUG CONTRAINDICATION; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; HEMODIALYSIS; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INFLAMMATION; KIDNEY FAILURE; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SODIUM RESTRICTION; VALVULAR CALCIFICATION;

ATHEROSCLEROSIS; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84879410728     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2012.12.001     Document Type: Review

References (37)

1. US Renal Data System URSDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-stage Renal Disease in the United States 2011 National Institutes of Health Bethesda
2. D.E. Weiner, S. Tabatabai, H. Tighiouart, E. Elsayed, N. Bansal, J. Griffith, D.N. Salem, A.S. Levey, and M.J. Sarnak Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease Am J Kidney Dis 48 2006 392 401 (Pubitemid 44247251)
3. A.S. Go, G.M. Chetow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
4. D.C. Wheeler, J.N. Townend, and M.J. Landray Cardiovascular risk factors in pre-dialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) Study Kidney Int 54 Suppl. 2003 4201 5203
5. E.L. Shiffrin, M.L. Lipman, and J.F.E. Mann Chronic kidney disease: effects on the cardiovascular system Circulation 116 2007 85 97 (Pubitemid 47016250)
6. V. Menon, A. Gul, and M.J. Sarnak Cardiovascular risk factors in chronic kidney disease Kidney Int 68 2005 1413 1418 (Pubitemid 43169885)
7. P.A. McCullough, S. Li, C.T. Jurkovitz, L. Stevens, A.J. Collins, S.C. Chen, K.C. Norris, S. McFarlane, B. Johnson, and M.G. Shilpak Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality Am Heart J 156 2008 277 283
8. E. Di Angelantonio, R. Chowdhary, N. Sarwar, J. Danesh, and V. Gudnason Chronic kidney disease and risk of major cardiovascular disease and non-vascular mortality: prospective population-based cohort study BMJ 2010 10.1136/bmj.c4986
9. S. Van der Zee, S. Elmariah, J. Winston, and V. Faster Cardiovascular risk factor in chronic kidney disease Nat Rev Cardiol 6 2009 580 589
10. J. Kendrick, and M.B. Chonchol Non-traditional risk factors for cardiovascular disease in patients with chronic kidney disease Nat Clin Pract 4 2008 672 681
11. P. Muntner, J. He, B.C. Astor, A.R. Foleon, and J. Coresh Traditional and non-traditional risk factors predicts coronary heart disease is chronic kidney disease: results from the Atherosclerosis Risk in Communities Study J Am Soc Nephrol 16 2005 529 538 (Pubitemid 41725151)
12. P.A. Smink, H.J. Lambers Heerspink, R.T. Gansevoort, P.E. de Jong, H.L. Hillege, S.J. Bakker, and D. de Zeeuw Albuminuria, estimated GFR, traditional risk factors and incident cardiovascular disease: the PREVEND (Prevention of Renal and Vascular End stage Disease) Study Am J Kidney Dis 60 2012 804 811
13. M.J. Sarnak, A.S. Levey, A.C. Schoolwerth, J. Coresh, B. Calleton, L.L. Hamm, P.A. McCullough, B.L. Kasiske, E. Kelepouris, and M.J. Klag Kidney disease as a risk factor for the development of cardiovascular disease Circulation 108 2003 2014 2169
14. R.A. Preston, and M. Epstein Renal parenchymal disease and hypertension Semin Nephrol 15 1998 138 151
15. C. Meisinger, A. Doring, H. Lowel, and KORA Study Group Chronic kidney disease and risk of incident myocardial infarction and all-cause and cardiovascular mortality in middle-aged men and women from the general population Eur Heart J 27 2006 1245 1250
16. P. Muntner, L.I. Hamm, J.W. Kusek, J. Chen, P.K. Whelton, and J. He The prevalence of non-traditional risk factors for coronary heart disease in patients with chronic kidney disease Ann Intern Med 140 2004 9 17
17. R.L. Jamison, P. Hartigan, J.S. Kaufman, D.S. Goldfarb, S.R. Warren, P.D. Guarino, J.M. Gaziano, and Veterans Affairs Site Visitors Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized, controlled trial JAMA 298 2007 1163 1170 (Pubitemid 47403102)
18. M.B. Nusair, N. Rajpurohit, and M.A. Alpert Chronic inflammation and coronary atherosclerosis in patients with end-stage renal disease Cardiorenal Med 2 2012 117 124
19. P. Stenvinkel, J. Carrero, J. Axelsson, B. Lindholm, O. Heimbarger, and Z. Massy Emerging biomarkers for evaluating cardiovascular risks in the chronic kidney disease patient: how do new pieces fit into the puzzle? Clin J Am Soc Nephrol 3 2008 508 521
20. P.O. Attman, and O. Samuelsson Dyslipidemia of kidney disease Curr Opin Lipidol 20 2009 293 299
21. C. Wanner, V. Krane, W. Marz, M. Olschewski, J.F. Mann, G. Ruf, E. Ritz, and German Diabetes and Dialysis Study Investigators Atorvastatin in patients with type 2 diabetes undergoing hemodialysis N Engl J Med 353 2005 238 248 (Pubitemid 41058323)
22. B.C. Fellstrom, A.G. Jardine, R.E. Schmieder, H. Holdaas, K. Bannister, J. Beutler, D.W. Chae, A. Chevale, S.M. Cobbe, and C. Gonhagen-Riska Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 2009 1395 1407
23. C. Baigent, M.J. Landray, C. Reith, J. Emberson, D.C. Wheeler, C. Tomson, C. Wanner, V. Krane, A. Cass, and J. Craig The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease, study of heart and renal protection: a randomized placebo-controlled trial Lancet 377 2011 2181 2192
24. J.R. Wu-wong Endothelial dysfunction and chronic kidney disease: treatment options Curr Opin Investig Drugs 9 2008 970 982
25. M. Annak, M. Zilmer, and B. Fellstrom Endothelium-dependent vasodilatation and oxidative stress in chronic renal failures Kidney Int 64 Suppl. 84 2003 550 553
26. D.V. Barreto, F.C. Barreto, A.B. Carvalho, C. Cuppari, M. Cendoroglo, S.A. Draibe, R.M. Moyses, K.R. Neves, V. Jorgetti, and A. Blair Coronary calcification in hemodialysis patients: the contribution of traditional and uremia-related risk factors Kidney Int 67 2005 1576 1582 (Pubitemid 40463138)
27. A.P. Sage, Y. Tintut, and L.L. Demer Regulatory mechanisms in vascular calcification Nat Rev Cardiol 7 2010 528 536
28. M. Ketteler, P. Bongartz, R. Westenfeld, J.E. Wildberger, A.H. Mahnken, R. Bohm, T. Metzger, C. Wanner, W. Jahnen-Dechent, and J. Floege Association of low fetuin A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross sectional study Lancet 361 2003 827 833 (Pubitemid 36331846)
29. R. Westenfeld, C. Schafer, T. Kruger, C. Haarmann, L.J. Schurgers, C. Reutelingsperger, O. Ivanovski, T. Drueke, Z.A. Massy, and M. Ketteler Fetuin-A protects against atherosclerotic calcification in CKD J Am Soc Nephrol 20 2009 1264 1274
30. J. Park Cardiovascular risk in chronic kidney disease: role of the sympathetic nervous system Cardiol Res Pract 2012 (2012:319432, E-pub)
31. M.G. Shilpak, R. Katz, M.J. Sarnak, L.F. Fried, A.B. Newman, C. Stehman-Breen, S.L. Seliger, B. Kestenbaum, B. Psaty, and R.B. Tracy Cystatin C and the risk of death and cardiovascular events among elderly persons N Engl J Med 352 2005 2049 2060 (Pubitemid 40664306)
32. M. Kanbay, M. Ikizek, Y. Solak, Y. Selcoki, S. Uysal, F. Armutou, B. Eryonucu, A. Covic, and R.J. Johnson Uric acid and pentraxin-3 levels are independently associated with coronary artery disease risk in patients with stage 2 and 3 kidney disease Am J Nephrol 3 2011 325 331
33. C. Nakano, T. Hamano, N. Fujii, I. Matsui, U. Tomida, S. Mikami, N. Inoue, Y. Obi, N. Okada, and Y. Tsubakihara Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis Bone 50 2012 1266 1274
34. R. Matsushita, van der Velde, B.C. Astor, M. Woodward, A.S. Levey, P.E. de Jong, J. Coresh, R.T. Gansevoort, and Chronic Kidney Disease Prognosis Consortium Association of glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population contorts: a collaborative meta-analysis Lancet 375 2010 2073 2081
35. M. van der Velde, R. Matsushita, J. Coresh, B.C. Astor, M. Woodward, A.S. Levey, P. de Jong, R.T. Gansevoort, A. Levey, and M. El-Nahas Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high risk population cohorts Kidney Int 79 2011 1341 1352
36. J. Fort Chronic renal failure. A cardiovascular risk factor Kidney Int 68 Suppl. 94 2005 825 829
37. M. Kaisar, N. Isbel, and D.W. Johnson Cardiovascular disease in patients with chronic kidney disease. A clinical review Minerva Urol Nephrol 59 2007 281 297 (Pubitemid 350205658)